Recombinant antibodies to human interleukin-1 beta
CA 2396212 C · Owner: Di Padova, Franco E. · Inventors: Di Padova, Franco E.; Gram, Hermann
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An IL-1.beta. binding molecule, in particular an antibody to human IL-1.beta. especially a human antibody to human IL-1.beta. is provided wherein the CDRs of the heavy and , light chains have amino acid sequences as defined, for use in the treatment of an IL-1 mediated disease or disorder, e. g, osteoarthritis osteoporosis and other inflammatory arthritides.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 19, 2001 and granted April 2, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.